(Q43981440)

28 November 2017

Methotrexate leukoencephalopathy presenting as Klüver-Bucy syndrome and uncinate seizures (English)

1 reference

28 November 2017

1 reference

Nuno Lobo Antunes

1

1 reference

28 November 2017

Mark M Souweidane

2

1 reference

28 November 2017

Eric Lis

3

1 reference

28 November 2017

Marc K Rosenblum

4

1 reference

28 November 2017

Peter G Steinherz

5

1 reference

28 November 2017

1 April 2002

1 reference

28 November 2017

1 reference

28 November 2017

26

1 reference

28 November 2017

4

1 reference

28 November 2017

305-308

1 reference

Transient cerebral dysfunction secondary to high-dose methotrexate

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900376-9

7 January 2021

Methotrexate treatment protocols and the central nervous system: significant cure with significant neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900376-9

7 January 2021

Neurotoxicity and Elevated Cerebrospinal-Fluid Methotrexate Concentration in Meningeal Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900376-9

7 January 2021

The human Klüver-Bucy syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900376-9

7 January 2021

Olfactory epileptic auras

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900376-9

7 January 2021

Leukoencephalopathy detectable by magnetic resonance imaging: much ado about nothing? Regarding Matsumoto et al. IJROBP 32:913-918; 1995

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900376-9

7 January 2021

Intellectual function in long-term survivors of childhood acute lymphoblastic leukemia: protective effect of pre-irradiation methotrexate? A Childrens Cancer Study Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900376-9

7 January 2021

Paraplegia following intrathecal methotrexate: report of a case and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900376-9

7 January 2021

Acute ascending myelitis and encephalopathy after intrathecal cytosine arabinoside and methotrexate in an adolescent boy with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900376-9

7 January 2021

Development of the anterior cingulate syndrome in a child due to delayed necrotising methotrexate leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900376-9

7 January 2021

Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900376-9

7 January 2021

Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900376-9

7 January 2021

Anatomical origin of déjà vu and vivid 'memories' in human temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900376-9

7 January 2021

Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900376-9

7 January 2021

10.1016/S0887-8994(01)00376-9

Identifiers

DOI

1 reference

28 November 2017

1 reference